Bullish option flow detected in Crispr Therapeutics with 4,527 calls trading, 3x expected, and implied vol increasing almost 3 points to 54.37%. Oct-23 65 calls and 6/30 weekly 59 calls are the most active options, with total volume in those strikes near 3,600 contracts. The Put/Call Ratio is 0.08. Earnings are expected on August 8th.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CRSP:
- Crispr Therapeutics call volume above normal and directionally bullish
- CRISPR Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results
- CRSP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- CRISPR Therapeutics to Participate Upcoming Investor Conferences
- Crispr Therapeutics options imply 2.4% move in share price post-earnings